Media
Presentations
Corporate Presentation
Download Presentation
Videos
OKYO CEO Gary Jacob talks to RedChip about the recent initiation of the Phase 2 trial for Neuropathic Corneal Pain (NCP) (Nov 2024)
Interview with OKYO Pharma CEO, Gary Jacob following the announcement of the early closure of NCP Trial to gain access to efficacy data. (April 2025)
OKYO CEO Gary Jacob talks to RedChip to Explain How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market (Aug 2024)
OKYO Pharma provides update on development of OK-101 (June 2024)
OKYO Pharma granted new patent for OK-101 to treat neuropathic pain
OKYO Pharma reaches milestone with first patient screening for dry eye disease trial
OKYO Pharma to take dry eye disease drug direct into Phase 2 clinical trials
OKYO CEO Gary Jacob talks to Jane King about the progress of the phase 2 trial with OK-101